CJC-1295 with DAC

CJC-1295 with DAC – Research Peptide CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic analogue of growth hormone-releasing hormone (GHRH), developed for research into extended growth hormone stimulation. The addition of DAC significantly increases the peptide’s half-life, enabling sustained GH release over several days. This makes it ideal for studies into continuous GH elevation, anti-aging mechanisms, and regenerative biology. Download Third Party COA: CJC-1295 COA – Batch 19430Independently verified by Janoshik, Batch 19430 is tested for >99% purity. Each vial is labelled for full traceability and research transparency. Batch Number: 19430 Molecular Formula: C165H269N47O46 Peptide Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser + DAC Research Only: Yes Batch Purity: 99.455 % Heavy Metals Report: See Report Endotoxin Test: See report Form: Lyophilised Solid Mixing Water Required: Yes Usage and Storage: CJC-1295 with DAC is supplied as a lyophilised powder for enhanced stability. Store in a cool, dry place away from direct sunlight. After reconstitution with sterile or bacteriostatic water, refrigerate and use within the advised timeframe. Peptide Mixing Notes Let both the peptide vial and mixing solution reach room temperature before reconstitution. Swirl gently to dissolve; do not shake, as this may degrade the peptide. ⚠️ Research Use Only – Important Legal Notice Used solely for in vitro experiments and cannot be: Used in clinical trials involving humans Administered to humans as part of an experiment or investigation, Supplied to another party for human investigational use.